NEW YORK (TheStreet) -- Shares of Welltower (HCN) are lower by 0.59% to $78.86 early Monday afternoon ahead of the company's 2016 second quarter results, due out before tomorrow's market open.

Wall Street is expecting that funds from operations and revenue will increase year-over-year.

Analysts surveyed by Thomson Reuters project that the healthcare real estate investment trust will post funds from operations of $1.14 per share on revenue of $1.04 billion.

Funds from operations is a key metric in the REIT industry, which takes net income and adds back items such as depreciation and amortization.

During the same quarter last year, the Toledo, OH-based company posted normalized funds from operations of $1.09 per diluted share on revenue of $957.2 million.

TheStreet Recommends

Separately, TheStreet Ratings Team has a "Buy" rating with a score of A- on the stock.

The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, good cash flow from operations, solid stock price performance and notable return on equity.

The team believes its strengths outweigh the fact that the company has had sub par growth in net income.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: HCN

Image placeholder title